April 18, 2018

Plenary Session

Plenary 1: “Global Health Economic and Econometrics {GHE2): Impact Evaluation of the National Health Policy”

The 5th InaHEA ASM bridges the balance of trade between imports from econometrics literature into health economics, and export from health economics to a wider audience. The key objective of the first plenary is to share and discuss an impact evaluation strategy, particularly in the application of advances health economics and econometrics methods, to detect a causal link between health care policy interventions on health outcomes. A case of the national health care policy intervention observed in three countries (Indonesia, Brazil and UK) will be presented, covering main policy initiatives made in each country, identification strategy to observe the impact, and the key findings. Discussions will be followed to dig more on how current GHE2 used in conducting impact assessment, as well as how the key findings should be connected to the policy refinements in each country.

 

Plenary 2: “Integrating End-stage HTA with MCDA: Decision-Oriented Evidence in Adopting Health Technology”

Decision making process on the adoption of health technology is always guided by several considerations. Specific criteria that should be taken into account in the decision making process, given resource scarcity, does often contradict with others considerations. The 5th InaHEA ASM is keen to tackling this by offering a plenary discussion aims to introduce how any decisions making process for the adoption of health technology, particularly medicine in Indonesia, could be reformed potentially. Presenters will discuss evidence over recent years on the supply-chain and demand for medicine, including (1) architecture of the past and current situation, (2) how current initiatives fits to the spirit of universal health coverage, and (3) what type of problems that are observed in the current supply and demand for medicine in Indonesia. Discussion also covered the issue of what might the proposed solutions either HTA alone or combining it with MCDA become more feasible to handle such identified problems, given existing architecture of the current decision making process in the country as well as prevailing political economy of health and health systems.

 

Plenary 3: “Considering Consumers Voices: Bridging the Knowledge-to-Action Gap”

In a global context, Health Technology Assessment (HTA) has become a main tools to provide an evidence in order to decide which alternative or benefit that should be provided to the patients. However, it must be quite tricky to ensure that the HTA result is clear on any conflict of interest. Because these result might affect to many perspective which of course has its own interest, such as government (ministry of health); NHI agency (BPJS Kesehatan); patients; clinician; healthcare providers; pharma industry; etc .Hence to address this issue, The 5th InaHEA is promoting this issue to be discussed by both national and international expert.

 

Plenary 4: “Considering Stakeholders Voices in the JKN System: Facilitating Stakeholders Concerns into President Actions”

In the fourth year implementation of JKN (Jaminan Kesehatan Nasional), there were several issues regarding to service management both in primary care and hospital level; payment system which “sometimes” induced fraud at the hospital level as a consequences of DRGs scheme; financial adequacy which affect to the deficits in some recent years; and many others important issues. While to consider on the stakeholder voices in JKN system, the 5th InaHEA will facilitate a panel discussion to address this issue towards President Actions. This panel discussion will involve a representative of healthcare providers; payer (BPJS Kesehatan); government (ministry of health); professional association; and patients.